Nhs Can't Use Rare Cancer Drug, Says Health Watchdog
Western Morning News, The › August 26, 2010
Linked as:
Summary
A cancer drug that has potential to stop rare tumours returning has been refused for use on the NHS owing to a lack of evidence, the health watchdog has said.
Glivec (imatinib) is already recommended as a treatment for patients with gastrointestinal stromal tumours (Gist) that cannot be removed by surgery.See the full content of this document
Extract
Nhs Can't Use Rare Cancer Drug, Says Health Watchdog
In its latest appraisal, the National Institute for Health and Clinical Excellence (Nice) examined ...
See the full content of this document
Sponsored links
